ArticleGenes2022
SemanticCAP: Chromatin Accessibility Prediction Enhanced by Features Learning from a Language Model.
Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
- Deciphering genomic codes using advanced natural language processing techniques: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2025Article
- DNA sequence analysis landscape: a comprehensive review of DNA sequence analysis task types, databases, datasets, word embedding methods, and language models.Frontiers in medicine · 2025Review
- Article
- The evolution and mutational robustness of chromatin accessibility in Drosophila.Genome biology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A large number of inorganic and organic compounds are able to bind DNA and form complexes, among which drug-related molecules are important. Chromatin accessibility changes not only directly affect drug-DNA interactions, but they can promote or inhibit the expression of the critical genes associated with drug resistance by affecting the DNA binding capacity of TFs and transcriptional regulators. However, the biological experimental techniques for measuring it are expensive and time-consuming. In recent years, several kinds of computational methods have been proposed to identify accessible regions of the genome. Existing computational models mostly ignore the contextual information provided by the bases in gene sequences. To address these issues, we proposed a new solution called SemanticCAP. It introduces a gene language model that models the context of gene sequences and is thus able to provide an effective representation of a certain site in a gene sequence. Basically, we merged the features provided by the gene language model into our chromatin accessibility model. During the process, we designed methods called SFA and SFC to make feature fusion smoother. Compared to DeepSEA, gkm-SVM, and k-mer using public benchmarks, our model proved to have better performance, showing a 1.25% maximum improvement in auROC and a 2.41% maximum improvement in auPRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.